Three Directors at Medibank Private Ltd bought 137,850 shares at between 3.950AUD and 3.960AUD. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
MEDIBANK PRIVATE (AU), a company active in the Life Insurance industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 1 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date February 8, 2022, the closing price w...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
The two narrow-moat private health insurers, Medibank Private and NIB Holdings are enjoying a reprieve from onerous Labor party policies following Labor’s surprise election loss on May 18, 2019. The reversal of negative election sentiment resulted in a strong increase in share prices as it became clear Labor’s policy of restricting premium rate increases to 2% per year for two years has been binned. Medibank’s share price increased 12% with NIB Holdings benefiting from a 13% increase. Desp...
The two narrow-moat private health insurers, Medibank Private and NIB Holdings are enjoying a reprieve from onerous Labor party policies following Labor’s surprise election loss on May 18, 2019. The reversal of negative election sentiment resulted in a strong increase in share prices as it became clear Labor’s policy of restricting premium rate increases to 2% per year for two years has been binned. Medibank’s share price increased 12% with NIB Holdings benefiting from a 13% increase. Desp...
The two narrow-moat private health insurers, Medibank Private and NIB Holdings are enjoying a reprieve from onerous Labor party policies following Labor’s surprise election loss on May 18, 2019. The reversal of negative election sentiment resulted in a strong increase in share prices as it became clear Labor’s policy of restricting premium rate increases to 2% per year for two years has been binned. Medibank’s share price increased 12% with NIB Holdings benefiting from a 13% increase. Desp...
Narrow-moat Medibank Private’s strong underlying performance for first-half fiscal 2019 was offset by a sharp drop in investment income, with NPAT of AUD 208 million down 15% on first half fiscal 2018 but up 4% on second-half fiscal 2018. Core businesses continue to deliver sound results with a small net increase in policyholder numbers, improved health insurance operating profit of AUD 282 million, and a strong uplift in Medibank Health operating profit to AUD 29 million. Despite lower invest...
Narrow-moat Medibank Private’s strong underlying performance for first-half fiscal 2019 was offset by a sharp drop in investment income, with NPAT of AUD 208 million down 15% on first half fiscal 2018 but up 4% on second-half fiscal 2018. Core businesses continue to deliver sound results with a small net increase in policyholder numbers, improved health insurance operating profit of AUD 282 million, and a strong uplift in Medibank Health operating profit to AUD 29 million. Despite lower invest...
Narrow-moat Medibank Private’s strong underlying performance for first-half fiscal 2019 was offset by a sharp drop in investment income, with NPAT of AUD 208 million down 15% on first half fiscal 2018 but up 4% on second-half fiscal 2018. Core businesses continue to deliver sound results with a small net increase in policyholder numbers, improved health insurance operating profit of AUD 282 million, and a strong uplift in Medibank Health operating profit to AUD 29 million. Despite lower invest...
The Minister for Health has approved an industrywide average increase in private health insurance premiums of 3.25%, effective April 1, 2019. We were expecting an increase around low 3.0% levels and welcome the lowest annual increase in decades. The slowdown in the rate of annual increase is due to lower claims inflation and lower hospital utilisation rates. Previous industrywide average premium increases were 3.95% for 2018, 4.84% for 2017, 5.59% for 2016, and 6.18% for 2015. Our AUD 2.95 per s...
The Minister for Health has approved an industrywide average increase in private health insurance premiums of 3.25%, effective April 1, 2019. We were expecting an increase around low 3.0% levels and welcome the lowest annual increase in decades. The slowdown in the rate of annual increase is due to lower claims inflation and lower hospital utilisation rates. Previous industrywide average premium increases were 3.95% for 2018, 4.84% for 2017, 5.59% for 2016, and 6.18% for 2015. Our AUD 2.95 per s...
Narrow-moat private health insurer, Medibank Private surprised with disappointing news its lucrative contract providing health services to the Australian Department of Defence will not be renewed when the current contract expires June 30, 2019. Medibank provided the service to the Government via its Medibank Health division. The Defence Department contract contributed approximately AUD 30 million in pretax operating profit in fiscal 2018, representing 5% of group operating profit. We have stripp...
The 2014 privatisation of Medibank Private Limited provided an attractive opportunity to invest in Australia's largest private health insurer. Expenditure on healthcare is expected to grow in the long term, driven by an increasing and ageing population. Operating in a heavily regulated industry, Australian health insurers typically produce stable and defensive earnings and, in our opinion, Medibank is well placed to produce solid long-term earnings growth. Future changes to regulations could hur...
Narrow-moat private health insurer, Medibank Private surprised with disappointing news its lucrative contract providing health services to the Australian Department of Defence will not be renewed when the current contract expires June 30, 2019. Medibank provided the service to the Government via its Medibank Health division. The Defence Department contract contributed approximately AUD 30 million in pretax operating profit in fiscal 2018, representing 5% of group operating profit. We have stripp...
Despite a softer-than-expected fiscal 2018 result, our positive view on narrow-moat-rated Medibank Private is intact. Good progress in improving the underlying business impressed with the health insurance operating profit up 8% to AUD 536 million and the health services business, known as Medibank Health, operating profit up 33% to AUD 47 million. The group NPAT margin of 6.4% was modestly below our 6.8% forecast. Lower-than-expected investment income, a higher tax rate, and higher other expense...
Despite a softer-than-expected fiscal 2018 result, our positive view on narrow-moat-rated Medibank Private is intact. Good progress in improving the underlying business impressed with the health insurance operating profit up 8% to AUD 536 million and the health services business, known as Medibank Health, operating profit up 33% to AUD 47 million. The group NPAT margin of 6.4% was modestly below our 6.8% forecast. Lower-than-expected investment income, a higher tax rate, and higher other expens...
Despite a softer-than-expected fiscal 2018 result, our positive view on narrow-moat-rated Medibank Private is intact. Good progress in improving the underlying business impressed with the health insurance operating profit up 8% to AUD 536 million and the health services business, known as Medibank Health, operating profit up 33% to AUD 47 million. The group NPAT margin of 6.4% was modestly below our 6.8% forecast. Lower-than-expected investment income, a higher tax rate, and higher other expens...
Despite a softer-than-expected fiscal 2018 result, our positive view on narrow-moat-rated Medibank Private is intact. Good progress in improving the underlying business impressed with the health insurance operating profit up 8% to AUD 536 million and the health services business, known as Medibank Health, operating profit up 33% to AUD 47 million. The group NPAT margin of 6.4% was modestly below our 6.8% forecast. Lower-than-expected investment income, a higher tax rate, and higher other expense...
Our positive view on narrow-moat Medibank Private is unchanged following the recent confirmation of the private health insurer’s strategy and outlook. Medibank remains well positioned to deliver meaningful business improvements, which will underpin future earnings growth. However, we acknowledge private health insurance affordability is a major threat and continues to constrain policyholder growth. Medibank is trading around 17.2 times forecast fiscal 2018 earnings, cheaper than the listed pee...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.